Respinova For Profit
Respinova is commercializing a breakthrough treatment for COPD, and a novel platform for deep lung drug delivery.
Founded Date:
2008-01-01
Headquarters:
Herzliya, Tel Aviv, Israel
Technology:
Biomarker panels
Employee Number:
N/A
Industry:
Clinical Data Management
Estimated Revenue:
$5 million
Number Of Exists:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A